Characterization of SV-40 Tag rats as a model to study prostate cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Harper, Curt E ^a   Patel, Brijesh B ^a   Cook, Leah M ^a   Wang, Jun ^a   Shirai, Tomoyuki ^b   Eltoum, Isam A ^c,d   Lamartiniere, Coral A ^a,d  

^a University of Alabama at Birmingham   (United States)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; MITOGEN ACTIVATED PROTEIN KINASE; SEX HORMONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TESTOSTERONE; ANDROGEN BINDING PROTEIN; BOLDENONE; DRUG DERIVATIVE; ESTRADIOL; PROBASIN; TUMOR PROTEIN; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOASSAY; INCIDENCE; MALE; NONHUMAN; PROSTATE CANCER; PROSTATE VENTRAL LOBE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; RAT; RAT STRAIN; SIMIAN VIRUS 40; SIMIAN VIRUS 40 T ANTIGEN RAT; AGE; ANIMAL; BLOOD; DISEASE MODEL; EVALUATION; IMMUNOLOGY; PATHOLOGY; PRECANCER; PROSTATE; PROSTATE TUMOR; TIME; VIROLOGY; WESTERN BLOTTING;

AGE FACTORS; ANDROGEN-BINDING PROTEIN; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ESTRADIOL; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC NEOPLASMS; RATS; SIMIAN VIRUS 40; TESTOSTERONE; TIME FACTORS;

EID: 60749084422     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-30     Document Type: Article

References (45)

1. American Cancer Society Global Cancer Facts and Figures American Cancer Society. Atlanta, GA 2007
2. Huggins C Hodges CV Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941 The Journal of Urology 2002, 168:9-12 10.1016/S0022-5347(05)64820-3 12050481
3. Imperato-McGinley J Guerrero L Gautier T Peterson RE Steroid 5alpha-reductase deficiency in man: An inherited form of male pseudohermaphroditism Science 1974, 186(1470):1213-1215 4432067 10.1126/ science.186.4170.1213
4. Gann PH Hennekens CH Ma J Longcope C Stampfer MJ Prospective study of sex hormone levels and risk of prostate cancer Journal of the National Cancer Institute 1996, 88:118-1126 10.1093/jnci/88.16.1118
5. Eaton NE Reeves GK Appleby PN Key TJ Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies British Journal of Cancer 1999, 80:930-934 10.1038/sj.bjc.6690445 10362098
6. Prins GS Birch L Habermann H Chang WY Tebeau C Putz O Bieberich C Influence of neonatal estrogens on rat prostate development Reproduction, Fertility, and Development 2001, 13:241-252 10.1071/ RD00107 11800163
7. Chan JM Stampfer MJ Ma J Gann P Gaziano JM Pollak M Giovannucci E Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer Journal of the National Cancer Institute 2002, 94:1099-1106 12122101
8. Torring N Vinter-Jensen L Pedersen SB Sorensen FB Flyvbjerg A Nexo E Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate The Journal of Urology 1997, 158:222-227 10.1097/00005392-199707000-00075 9186364
9. Ruan W Powell-Braxton L Kopchick JJ Kleinberg DL Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development Endocrinology 1999, 140:1984-1989 10.1210/ en.140.5.1984 10218945
10. Tennant MK Thrasher JB Twomey PA Drivdahl RH Birnbaum RS Plymate SR Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium The Journal of Clinical Endocrinology and Metabolism 1996, 81:3774-3782 10.1210/jc.81.10.3774
11. Robinson MJ Cobb MH Mitogen-activated protein kinase pathways Current Opinion in Cell Biology 1997, 9:180-186 10.1016/S0955-0674(97)80061-0 9069255
12. Yeh S Lin HK Kang HY Thin TH Lin MF Chang C From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America 1999, 96:5458-5463 21881 10318905 10.1073/pnas.96.10.5458
13. Greenberg NM DeMayo F Finegold MJ Medina D Tilley WD Aspinall JO Cunha GR Donjacour AA Matusik RJ Rosen JM Prostate cancer in a transgenic mouse Proceedings of the National Academy of Sciences of the United States of America 1995, 92:3439-3443 42182 7724580 10.1073/pnas.92.8.3439
14. Asamoto M Hokaiwado N Cho YM Takahashi S Ikeda Y Imaida K Shirai T Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent Cancer Research 2001, 61:4693-4700 11406539
15. Wang J Eltoum IE Lamartiniere CA Genistein chemoprevention of prostate cancer in TRAMP mice Journal of Carcinogenesis 2007, 6:3 1832183 17367528 10.1186/1477-3163-6-3
16. Shappell SB Thomas GV Roberts RL Herbert R Ittmann MM Rubin MA Humphrey PA Sundberg JP Rozengurt N Barrios R Ward JM Cardiff RD Prostate pathology of genetically engineered mice: Definitions and classification Cancer Research 2004, 64:2270-2305 10.1158/0008-5472.CAN-03-0946 15026373
17. Price D Comparative Aspects of Development and Structure in the Prostate National Cancer Institute Monograph 1963, 12:1-27 14072991
18. Folkvord JM Viders D Coleman-Smith A Clark RA Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens J Histochem Cytochem 1989, 37(1):105-113 2461979
19. Wechter WJ Leipold DD Murray ED Jr Quiggle D McCracken JD Barrios RS Greenberg NM E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse Cancer Research 2000, 60:2203-2208 10786685
20. Kaplan-Lefko PJ Chen TM Ittmann MM Barrios RJ Ayala GE Huss WJ Maddison LA Foster BA Greenberg NM Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model The Prostate 2003, 55:219-237 10.1002/pros.10215 12692788
21. Harper C Patel BB Wang J Eltoum IE Lamartiniere CA Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: Mechanisms of action The Prostate 2007, 67:1576-1589 10.1002/pros.20643 17705241
22. Wang J Eltoum IE Lamartiniere CA Genistein alters growth factor signaling in transgenic prostate model (TRAMP) Mol Cell Endocrinol 2004, 219:171-180 10.1016/j.mce.2003.12.018 15149738
23. Crowther JR The ELISA guidebook Methods in Molecular Biology. Clifton, NJ 2000, 149:1-413
24. Wikstrom P Lindahl C Bergh A Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy The Prostate 2005, 62:148-164 10.1002/pros.20123 15389804
25. Cho YM Takahashi S Asamoto M Suzuki S Inaguma S Hokaiwado N Shirai T Age-dependent histopathological findings in the prostate of probasin/ SV40 T antigen transgenic rats: Lack of influence of carcinogen or testosterone treatment Cancer Science 2003, 94:153-157 10.1111/ j.1349-7006.2003.tb01412.x 12708490
26. Gingrich JR Barrios RJ Morton RA Boyce BF DeMayo FJ Finegold MJ Angelopoulou R Rosen JM Greenberg NM Metastatic prostate cancer in a transgenic mouse Cancer Research 1996, 56:4096-4102 8797572
27. Prins GS Huang L Birch L Pu Y The role of estrogens in normal and abnormal development of the prostate gland Annals of the New York Academy of Sciences 2006, 1089:1-13 2276871 17261752 10.1196/ annals.1386.009
28. Kandori H Suzuki S Asamoto M Murasaki T Mingxi T Ogawa K Shirai T Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats Cancer Science 2005, 96:221-226 10.1111/j.1349-7006.2005.00041.x 15819720
29. Tang M Ogawa K Asamoto M Hokaiwado N Seeni A Suzuki S Takahashi S Tanaka T Ichikawa K Shirai T Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells Cancer Science 2007, 98:471-477 10.1111/j.1349-7006.2007.00417.x 17284254
30. Zeng Y Yokohira M Saoo K Takeuchi H Chen Y Yamakawa K Matsuda Y Kakehi Y Imaida K Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor Carcinogenesis 2005, 26:1109-1116 10.1093/carcin/bgi056 15731164
31. Resko JA Feder HH Goy RW Androgen concentrations in plasma and testis of developing rats The Journal of Endocrinology 1968, 40:485-491 10.1677/ joe.0.0400485 5643421
32. Corpechot C Baulieu EE Robel P Testosterone, dihydrotestosterone and androstanediols in plasma, testes and prostates of rats during development Acta Endocrinologica 1981, 96:127-135 7456981
33. Berger M Jean-Faucher C de Turckheim M Veyssiere G Jean C Testicular and plasma androgens in newborn, immature, adult and aging mice Archives Internationales de Physiologie et de Biochimie 1975, 83:239-253 10.3109/ 13813457509081868 54056
34. Chan JM Stampfer MJ Giovannucci E Gann PH Ma J Wilkinson P Hennekens CH Pollak M Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study Science 1998, 279:5350-563 566 9438850 10.1126/ science.279.5350.563
35. Wolk A Mantzoros CS Andersson SO Bergstrom R Signorello LB Lagiou P Adami HO Trichopoulos D Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study Journal of the National Cancer Institute 1998, 90:911-915 10.1093/jnci/90.12.911 9637140
36. Mantzoros CS Tzonou A Signorello LB Stampfer M Trichopoulos D Adami HO Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia British Journal of Cancer 1997, 76:1115-1118 9365156
37. Sjogren K Liu JL Blad K Skrtic S Vidal O Wallenius V LeRoith D Tornell J Isaksson OG Jansson JO Ohlsson C Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proceedings of the National Academy of Sciences of the United States of America 1999, 96:7088-7092 22065 10359843 10.1073/pnas.96.12.7088
38. Sakr WA Haas G Cassin BF Pontes JE Crissman JD The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients The Journal of Urology 1993, 150:379-385 8326560
39. DeCaprio JA Ludlow JW Figge J Shew JY Huang CM Lee WH Marsilio E Paucha E Livingston DM SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene Cell 1998, 54:275-283 10.1016/0092-8674(88)90559-4
40. Lane DP Crawford LV T antigen is bound to a host protein in SV40-transformed cells Nature 1979, 278:261-263 10.1038/278261a0 218111
41. Linzer DI Levine AJ Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells Cell 1979, 17:43-52 10.1016/0092-8674(79)90293-9 222475
42. Pallas DC Shahrik LK Martin BL Jaspers S Miller TB Brautigan DL Roberts TM Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A Cell 1990, 60:167-176 10.1016/0092-8674(90)90726-U 2153055
43. Asamoto M Hokaiwado N Cho YM Shirai T Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control Carcinogenesis 2002, 23:463-467 10.1093/carcin/23.3.463 11895861
44. Gingrich JR Barrios RJ Kattan MW Nahm HS Finegold MJ Greenberg NM Androgen-independent prostate cancer progression in the TRAMP model Cancer research 1997, 57:4687-4691 9354422
45. Eng MH Charles LG Ross BD Chrisp CE Pienta KJ Greenberg NM Hsu CX Sanda MG Early castration reduces prostatic carcinogenesis in transgenic mice Urology 1999, 54:1112-1119 10.1016/S0090-4295(99)00297-6 10604719